Patients May Benefit from Molecular Profiling of Tumor BRAF, PI3K, etc, would benefit from available drugs

Santosh Kesari, MD, explains Patients May Benefit from Molecular Profiling of Tumor BRAF, PI3K, etc, would benefit from available drugs at the 2018 Oncology Summit in Huntington Beach, CA

Go to: http://www.moasc.org for more information